VanEck Pharmaceutical ETF (PPH)
VanEck
- Page updated:
- Sep 7, 2026
Fund identity
- Ticker
- PPH
- Fund name
- VanEck Pharmaceutical ETF
- Fund type
- ETF
- Currency
- USD
- Domicile
- US
- Inception
- Dec 20, 2011
Structure and strategy
- Sponsor
- VanEck
- Management approach
- Passive
- Strategy
- Tracks U.S.-listed pharmaceutical companies, including U.S. and foreign issuers with U.S. listings.
- Portfolio scope
- U.S.-listed pharmaceutical equities
- Portfolio implementation
- Index tracking
- Benchmark
- MVIS US Listed Pharmaceutical 25 Index
- Benchmark symbol
- MVPPHTR
- Asset class
- Equity
- Category
- Pharmaceuticals
Costs and minimums
- Net expense ratio
- 0.36%
- Net expense ratio
- 0.36%
- Ongoing fee as of
- Sep 7, 2026
Sources
- VanEck Pharmaceutical ETF — issuer product page — VanEck · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.